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Bacterial nanocellulose (BNC) is a nanofibrilar exopolysaccharide synthesized by certain Gram-negative, 
obligate aerobic, acetic acid bacteria, the Komagataeibacter genus being the most important due to the 
high cellulose yield obtained. The unique properties of this biopolymer have supported a wide range of 
potential applications, in human and veterinary medicine, odonthology, pharmaceutical industry, 
acoustic and filter membranes, biotechnological devices and in the food and paper industry. The large-
scale production of BNC, through advanced biotechnology has eluded many researches. Historical 
attempts but on low volume and high-value (mostly for biomedical applications) production can be 
traced back to the 90s. 
This presentation will show the main work with BNC by the Funcarb group. Examples of these studies 
will include the use of BNC in biomedical and food applications. Finally, an overview on the main efforts 
towards the production of BNC at large scale and potential markets will also be presented.  
 
 
